LLY · Healthcare
Eli Lilly & Co
53/100
Smart-money confidence1 of 3 sources positive
Moderate — mixed signals
No standout activity across the feeds we track.
Hedge funds
70
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$1.10T
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About ELI LILLY & CO
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the…
Who's behind the signal
Every informed buyer we can see on LLY, across all three feeds.
Hedge funds · 12
ARK Invest (Cathie Wood)
New position
Tudor Investment (Paul Tudor Jones)
Increased +167%
D.E. Shaw & Co
Increased +52%
AQR Capital Management
Increased +69%
Point72 (Steve Cohen)
Increased +41%
Gotham Asset Mgmt (Greenblatt)
Increased +43%
+6 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 18 on record
Disclosures from 2020-02-20 to 2026-01-02
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2026-01-02 | Michael A. Rulli · R-OH | House | Bought | $1,001 - $15,000 |
| 2025-04-15 | Tommy Tuberville · R-AL | Senate | Sold | $15,001 - $50,000 |
| 2022-08-04 | Bob Gibbs · R-OH | House | Sold | $1,001 - $15,000 |
| 2022-04-28 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-04-14 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-03-29 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-03-16 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2021-03-05 | Michael T. McCaul · R-TX | House | Sold | $250,001 - $500,000 |
| 2021-02-05 | Kurt Schrader · D-OR | House | Bought | $1,001 - $15,000 |
| 2020-10-26 | Kurt Schrader · D-OR | House | Bought | $1,001 - $15,000 |
Show the other 8
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2020-10-02 | Kurt Schrader · D-OR | House | Bought | $1,001 - $15,000 |
| 2020-09-01 | Kurt Schrader · D-OR | House | Bought | $1,001 - $15,000 |
| 2020-06-03 | Kurt Schrader · D-OR | House | Bought | $1,001 - $15,000 |
| 2020-04-16 | David Perdue · R-GA | Senate | Sold | $1,001 - $15,000 |
| 2020-04-07 | Kelly Loeffler · R-GA | Senate | Bought | $1,001 - $15,000 |
| 2020-03-26 | Steve Cohen · D-TN | House | Sold | $1,001 - $15,000 |
| 2020-03-13 | Van Taylor · R-TX | House | Sold | $500,001 - $1,000,000 |
| 2020-02-20 | Mikie Sherrill · D-NJ | House | Sold | $1,001 - $15,000 |
Not a model pick — but on our radar.
ELI LILLY & CO isn't in the top-10 model right now, but 12 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
12
Investors
1
New positions
5
Increasing
3
Decreasing
3
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.3×
% of portfolio
0.1%
Position change
NEW
0.1% of ARK Invest's portfolio
Trust weight: 1.2×
% of portfolio
0.6%
Position change
+167%
0.6% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.5%
Position change
+52%
0.5% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.4%
Position change
+69%
0.4% of AQR Capital Management's portfolio
Trust weight: 1.1×
% of portfolio
0.2%
Position change
+41%
0.2% of Point72's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+43%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.8%
Position change
—
0.8% of Elliott Investment Mgmt's portfolio
Trust weight: 1.5×
% of portfolio
0.4%
Position change
—
0.4% of Soros Fund Management's portfolio
Trust weight: 1.3×
% of portfolio
0.3%
Position change
−3%
0.3% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
−18%
0.2% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
−66%
0.2% of Citadel Advisors's portfolio
Trust weight: 1.3×
% of portfolio
0.1%
Position change
—
0.1% of Polen Capital Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ELI LILLY & CO
No insider trades found in the last 90 days
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ELI LILLY & CO or any security.
订阅每周更新
我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订